GRAIL to Announce First Quarter 2026 Financial Results
MENLO PARK, Calif., April 22, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
MENLO PARK, Calif., April 22, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
Company accelerates AI-enabled fracture detection development, compressing anticipated FDA 510(k) timelineCHARLOTTESVILLE, Va., April 22, 2026 /PRNewswire/ -- RIVANNA®, developer of...
Detailed NHS-Galleri Trial Results Will be Presented as a Late-Breaking Abstract in an Oral Presentation Final PATHFINDER 2 Study Results...
CAMBRIDGE, Mass. and CAMBRIDGE, England, April 21, 2026 /PRNewswire/ -- As AI accelerates across biopharma and other science-driven industries, organizations...
CAMBRIDGE, Mass. and CAMBRIDGE, England, April 21, 2026 /PRNewswire/ -- As AI accelerates across biopharma and other science-driven industries, organizations...
CAMBRIDGE, Mass. and CAMBRIDGE, England, April 21, 2026 /PRNewswire/ -- As AI accelerates across biopharma and other science-driven industries, organizations...
CAMBRIDGE, Mass. and CAMBRIDGE, England, April 21, 2026 /PRNewswire/ -- As AI accelerates across biopharma and other science-driven industries, organizations...
SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...
SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...
SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...
Collaboration aims to identify biological signatures and patient subpopulations most likely to benefit from BioAegis’ recombinant human plasma gelsolin (rhu-pGSN),...
Surge in AI & IoT-enabled smart wearables, rising healthcare monitoring demand, and expanding enterprise deployments are reshaping the global wearable...
Eclipsebio's eCOMPASS™ platform integrates AI-optimized RNA design (eNAVIGATE™), in-house prototyping at R&D scale, and deep sequencing-based characterization (eMERGE™) into a...
IRVING, Texas, April 20, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and...
Three-pillar framework sets methodological benchmark for data quality and transparency in oncology dataNEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the publication...
IRVING, Texas, April 17, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision...
Live event to be held on Thursday, April 23, at 2:00 p.m. ET Company focused on advancing launch strategy ahead...
WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition...
AI-driven command and control platform applied in real-world railway operations, supporting broader infrastructure and security use casesNETANYA, Israel, April 16,...
Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research...